Saudi Arabia Veterinary Pharmaceuticals Market Report, Size, Share, Opportunities, And Trends By Type (Injectable, Oral, Topical, Auricular, Ophthalmic, And Nasal), By Animal Type (Companion Animal, Production Animal), And End-Use (Vet Hospitals, Animal Farms, Others) - Forecasts From 2025 To 2030

Description

Saudi Arabia Veterinary Pharmaceuticals Market Size:

The Saudi Arabia Veterinary Pharmaceuticals market is expected to grow at a compound annual growth rate (CAGR) of 6.66% from US$36.544 million in 2025 to US$50.451 million in 2030.

To learn more about this report, request a free sample copy

The field of medical science that focuses on the diagnosis, treatment, prevention, and general healthcare of animals is known as veterinary medicine or just vet medicine. It includes a broad spectrum of medical procedures and offerings aimed at guaranteeing the health and welfare of animals, both tamed and wild. Veterinarians offer animals complete medical care, including vaccinations, surgeries, dental care, and specialized treatments in addition to routine checkups. Their objective is to preserve and enhance the well-being and standard of living of animals. An essential component of veterinary pharmaceuticals is preventive care. It comprises preventative measures to avoid illness and guarantee the long-term health of animals, such as vaccinations, parasite control, wellness examinations, and dietary advice.

Surgical procedures performed by veterinarians range from simple spaying and neutering to intricate operations to treat congenital conditions, remove tumors, and treat injuries. In veterinary medicine, surgical procedures are similar to those in human medicine. Moreover, the need for animal production is also being fueled by Saudi Arabia's increasing demand for dairy and meat due to the country's increased need for protein and animal-based products. For instance, according to the Foreign Agricultural Service. Saudi Arabia is promoting the growth of poultry farming in the country.

The Ministry of Environment, Water, and Agriculture announced the issuance of new licenses in the poultry production and breeding sector in the Kingdom, amounting to 275 new licenses. 119 licenses for broiler projects, 26 new projects to produce eggs with a production capacity of more than two billion eggs per year, and 12 projects to breed and produce broiler mothers and operate hatcheries. The demand for veterinary vaccines to maintain good veterinary health in Saudi Arabia is being further driven by the trend toward increased animal consumption and production indicators and an overall increase in the demand for agricultural livestock.

Further, pets are becoming more and more important in Saudi Arabian households, which has increased demand for veterinary care and pet supplies like food, medicine, and vaccinations. Animal health, including vaccinations and disease control strategies, is receiving more attention as a result of worries about zoonotic diseases, or illnesses that can spread from animals to people. Improvements in veterinary medicine, including better medications, diagnostic equipment, and therapeutic techniques, have broadened the selection of goods and services available, propelling market expansion. The market has grown as a result of growing awareness among veterinarians, livestock farmers, and pet owners of the value of preventive care and veterinary care. For instance, in April 2022, ADQ and E20 Investment Ltd. collaborated to launch a novel animal health platform in Abu Dhabi, signifying a noteworthy achievement for the country's animal healthcare industry. The medical platform is built around two state-of-the-art veterinary clinics and a state-of-the-art vaccine production facility. The facilities offer the most cutting-edge technological animal vaccinations for the Middle East and Africa (MEA) region, further solidifying Abu Dhabi's position as a regional superpower in the field of upscale veterinary care for horses and camels.

Further, the market is also anticipated to be driven during the forecast period by an increase in the number of veterinary hospitals and clinics in Saudi Arabia. The market for veterinary care has been significantly impacted by the rise in pet ownership in Saudi Arabia. As a result, the need for veterinary clinics in the area has increased. It is also expected that the market will expand due to the rise in veterinary pharmacies. Furthermore, it is anticipated that rising sales of over-the-counter medications and other goods will offer lucrative opportunities for industry players. For instance, Saudi Arabia's Qassim Gov. Prince Faisal bin Mishaal opened the largest camel hospital in the world in July 2022. Saudi Arabia's veterinary hospitals strive to treat animals as best they can by utilizing a variety of techniques and technological advancements. The market is anticipated to grow as a result of ongoing improvements to the services and facilities offered, such as central laboratories equipped with contemporary equipment.

Saudi Arabia Veterinary Pharmaceuticals Market Overview & Scope:

The Saudi Arabia Veterinary Pharmaceuticals Market is segmented by:

• Type: The oral route of administration holds the largest share in the Saudi Arabian veterinary pharmaceuticals market driven by its ease of administration, cost-effectiveness, and suitability for long-term treatments such as anti-parasitics and nutritional supplements.
• Animal Type: The production animal segment is expected to grow at a significant rate in the Saudi Arabian market due to high demand for meat, dairy, and animal-based products, which is also supported by a growing population, coupled with the demand for protein needs in the country.
• End-User: The veterinary hospitals and clinics segment is expected to hold the major share in the Saudi Arabian veterinary pharmaceuticals market because of the rising pet ownership, expansion of veterinary infrastructure, and improved services like advanced diagnostics and treatments.

Top Trends Shaping the Saudi Arabia Veterinary Pharmaceuticals Market:

1. Integration of Advanced Technology
   The range of innovative diagnostic techniques, such as blood tests, imaging, and laboratory testing, is increasingly developed and employed by veterinarians to detect and manage medical conditions in animals.

Saudi Arabia Veterinary Pharmaceuticals Market Growth Drivers vs. Challenges:

Drivers:

• Rising Pet Ownership: There is a significant increase and growth in the pet industry in Saudi Arabia and its related sectors, such as food, grooming tools, accessories, and veterinary equipment. The key driver behind the growth of the pet products market in Saudi Arabia is the rising disposable income among households. With higher incomes, pet owners are more willing to spend on multiple products for their pets, including healthcare.

This massive shift in the pet market has led to an expansion of product offerings in the market, with the healthcare and wellness segment of the Saudi Arabian pet products market also witnessing a rise, as pet owners are becoming aware of their pets’ health and seek out preventive and curative healthcare products, such as supplements, vitamins, and specialized treatments. Several other factors, such as the increasing number of veterinary clinics. There are 434 clinics, and the number of specialized veterinary pharmacies is 1366, specializing in meeting the needs in 2023. Further, the availability of pet insurance and veterinary services has also caused a surge in the overall market.

• Increasing number of vet hospitals and clinics: Several factors are driving the growth of the market, such as the rising popularity of pet ownership, followed by the improved services provided by the veterinary hospitals and clinics in Saudi Arabia. The use of companion animals is on the rise, especially dogs and cats; therefore, the surge in the demand for veterinary services is also on the rise. According to the article published by Global Pets on the Pet Industry of Saudi Arabia in 2023, it was reported that pet ownership in the country has been booming in recent years. In 2022, the market for pet care was worth $89.7 million in Saudi Arabia, whereas this figure in the year 2023 has reached a total of $137.7 million, which is an increase of more than 50%.

An increase in the number of households that own a pet is a factor that stimulates the growth of veterinary hospitals and clinics. Besides, with this expansion, the veterinary hospitals and clinics in Saudi Arabia are also improving the type of services that they offer, including extensive treatments, sophisticated diagnostic facilities, as well as specialty care. The introduction of improved service standards further enhances the segment's attractiveness, thus ensuring growth in the number of pet owners.

The Saudi Arabian government has also implemented policies to support the agricultural sector, which includes the veterinary industry. This support has fostered the development of veterinary facilities and hence has been partly responsible for the increase in the hospitals and clinics segment. Besides, the extent of knowledge concerning pet owners and livestock farmers about the necessity of veterinary visits and preventive measures, as well as disease prevention and control, has also improved. This awareness, as a result in leading to an increase in the demand for pets’ drugs and vaccines, hence promoting the hospitals and clinics segment. Furthermore, things like better diagnosis tools and treatment procedures have enabled veterinary hospitals and clinics in Saudi Arabia to realize greater capacity. These have enhanced the attractiveness of many clients and helped in the growth of the segment.

Challenges:

• Limited Access in Remote Areas: The veterinary pharmaceuticals, including drugs, specialized medication, and their associated services, are limited or have no reach in rural and remote regions of the country, which could affect the livestock-dependent individuals.

Saudi Arabia Veterinary Pharmaceuticals Market is analyzed into the following segments:

• By animal type, production animals are anticipated to hold a substantial market share

The Saudi Arabian veterinary pharmaceuticals market for producing animals is expanding rapidly due to several major factors. Primarily, the rising demand for meat and dairy products in the country, driven by population growth and changing dietary trends, has resulted in the rise of the livestock sector. In this regard, the consumption of beef and veal in the Kingdom rose from 219.7 thousand tonnes in 2022 to 226.1 thousand tonnes in 2023, as per the OECD. This has increased the need for animal healthcare solutions.

Further, the increase in chicken meat production in Saudi Arabia is directly driving the expansion of the veterinary medicines industry. USDA declared the country’s chicken meat production in 2023 to be 1,150 thousand metric tons. A greater poultry population demands more disease prevention and control methods, which increases demand for vaccinations, antibiotics, and other veterinary supplies. This emphasis on animal health eventually increases poultry farmers' production and profitability, which benefits both the poultry business and the veterinary pharmaceutical sector.

Furthermore, the frequency of animal illnesses poses a substantial danger to livestock productivity, emphasizing the role of veterinary medications in disease prevention and control. The increased awareness of animal welfare is also pushing the adoption of better healthcare methods, such as the use of veterinary medications. Nonetheless, the sector offers tremendous prospects. Creating novel veterinary solutions customized to the unique demands of the Saudi livestock sector is a great opportunity. Concentrating on specialist markets, such as high-value dairy cattle or specialized poultry breeds, may also be beneficial. Collaboration with local distributors and vets can help businesses gain a better market presence.

For instance, Saheliya’s primary goal is to supply high-quality livestock and poultry medications at cheap costs. While the company continues to grow and expand its services, its focus remains on veterinary anti-inflammatories, anti-parasitics, and antibiotics, accounting for more than 25% of livestock antibiotics in the Kingdom of Saudi Arabia.

MM Group also expanded into the veterinary medicines market by building a branch in Malaz, Riyadh. The company is the only agent for Avico Veterinary pharmaceutical goods and services in the Kingdom of Saudi Arabia. Avico's veterinary products adhere to the world's top animal health care standards. MM Group deals with a wide range of veterinary products and services for cattle, poultry, horses, and home pets.

Saudi Arabia Veterinary Pharmaceuticals Market Competitive Landscape:

The market is fragmented, with many notable players, including Montajat Veterinary Pharmaceuticals Co., Ltd., Vetoquinol, Saudi Pharmaceutical Industries SPI, Pharma Care Leading Manufacturing Co., Ltd., Salehiya Healthcare, Merck & Co., Boehringer Ingelheim International GmbH, Elanco, Alkhoraif Veterinary Company, and Vetanco, among others.

• Partnership: May 2025, Vetanco partners with Arasco for offering distribution rights of its veterinary pharmaceutical products to Arasco through its subsidiary AI-Emar International in Saudi Arabia.

Saudi Arabia Veterinary Pharmaceuticals Market Scope:

Saudi Arabia Veterinary Pharmaceuticals Market Segmentation:

• By Type
  • Injectable
  • Oral
  • Topical
  • Auricular, Ophthalmic, and Nasal
• By Animal Type
  • Companion Animal
  • Production Animal
• By End User
  • Vet Hospitals and Clinics
  • Animal Farms
  • Others

Table Of Contents

1. EXECUTIVE SUMMARY 

2. MARKET SNAPSHOT

2.1. Market Overview

2.2. Market Definition

2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE 

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities 

3.4. Porter’s Five Forces Analysis

3.5. Industry Value Chain Analysis

3.6. Policies and Regulations 

3.7. Strategic Recommendations 

4. TECHNOLOGICAL OUTLOOK 

5. SAUDI ARABIA VETERINARY PHARMACEUTICALS MARKET BY PRODUCT TYPE

5.1. Introduction

5.2. Injectable

5.3. Oral

5.4. Topical

5.5. Auricular, Ophthalmic, and Nasal

6. SAUDI ARABIA VETERINARY PHARMACEUTICALS MARKET BY ANIMAL TYPE

6.1. Introduction

6.2. Companion Animal

6.3. Production Animal

7. SAUDI ARABIA VETERINARY PHARMACEUTICALS MARKET BY END USER

7.1. Introduction

7.2. Vet Hospitals and Clinics

7.3. Animal Farms

7.4. Others

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

8.1. Major Players and Strategy Analysis

8.2. Market Share Analysis

8.3. Mergers, Acquisitions, Agreements, and Collaborations

8.4. Competitive Dashboard

9. COMPANY PROFILES

9.1. Montajat Veterinary Pharmaceuticals  Co., Ltd.

9.2. Vetoquinol 

9.3. Saudi Pharmaceutical  Industries SPI

9.4. Pharma Care Leading Manufacturing  Co. Ltd. 

9.5. Salehiya  Healthcare

9.6. Merck &  Co.

9.7. Boehringer  Ingelheim International GmbH

9.8. Elanco 

9.9. Alkhoraif Veterinary Company 

9.10. Vetanco 

10. APPENDIX

10.1. Currency 

10.2. Assumptions

10.3. Base and Forecast Years Timeline

10.4. Key benefits for the stakeholders

10.5. Research Methodology 

10.6. Abbreviations 

Companies Profiled

Montajat Veterinary Pharmaceuticals Co., Ltd.

Vetoquinol

Saudi Pharmaceutical Industries SPI

Pharma Care Leading Manufacturing Co. Ltd. 

Salehiya Healthcare

Merck & Co.

Boehringer Ingelheim International GmbH

Elanco

Alkhoraif Veterinary Company

Vetanco

Related Reports